Vimseltinib (DCC-3014) is a highly selective, orally active inhibitor of colony-stimulating factor-1 receptor (CSF-IR) and c-Kit with IC50 values of
Vimseltinib (DCC-3014) is a highly selective, orally active inhibitor of colony-stimulating factor-1 receptor (CSF-IR) and c-Kit with IC50 values of
Vinblastine sulfate is an anti-mitotic agent which arrests the cell cycle in the G2/M-phase.
Vinblastine sulfate is an anti-mitotic agent which arrests the cell cycle in the G2/M-phase.
Vinblastine sulfate is an anti-mitotic agent which arrests the cell cycle in the G2/M-phase.
Vincamine can be used as a peripheral vascular dilator (Vasodilator) to selectively regulate cerebral microvascular circulation. Vincamine is a GPR40 agonist that plays a beta-cell protective role by improving beta-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS). Vincamine can improve glucose homeostasis in vivo and has...
Vincamine can be used as a peripheral vascular dilator (Vasodilator) to selectively regulate cerebral microvascular circulation. Vincamine is a GPR40 agonist that plays a beta-cell protective role by improving beta-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS). Vincamine can improve glucose homeostasis in vivo and has...
Vincristine, formally known as leurocristine, is a mitotic inhibitor used in cancer chemotherapy.
Vincristine, formally known as leurocristine, is a mitotic inhibitor used in cancer chemotherapy.
Vincristine, formally known as leurocristine, is a mitotic inhibitor used in cancer chemotherapy.